Tarsus Pharmaceuticals, Inc.
TARS
Revenue
40.81M
▲13.20M▲47.80%
3 Months ChangeAssets
376.84M
▲27.57M▲7.89%
3 Months ChangeLiabilities
124.60M
▲50.53M▲68.22%
3 Months ChangeFree Cash Flow
-37.96M
▼-15.65M▼-70.16%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0001819790-24-000111
2024-08-08
Form 8-K
ID: 0001819790-24-000109
2024-06-18
Form 8-K
ID: 0001819790-24-000087
2024-05-08
Form 10-Q
ID: 0001819790-24-000063
2024-05-08
Form 8-K
ID: 0001819790-24-000062
2024-04-23
Form 8-K
ID: 0001819790-24-000050
2024-03-05
Form 8-K
ID: 0001819790-24-000024
2024-03-01
Form 8-K
ID: 0001193125-24-056209
2024-02-27
Form 8-K
ID: 0001819790-24-000015
2024-01-18
Form 8-K
ID: 0001819790-24-000006